Reply to: “Does currently recommended maternal antiviral prophylaxis against mother-to-child transmission of hepatitis B virus require enhancement?”

• Philippa C. Matthews,
• Ponsiano Ocama,
• Su Wang,
• Manal El-Sayed,
• Anna Turkova,
• Deborah Ford,
• Judith Torimiro,
• Ana Cristina Garcia Ferreira,
• Angélica Espinosa Miranda,
• Fernando Pio De La Hoz Restrepo,
• Emmanuel Seremba,
• Robinson Mbu,
• Calvin Q. Pan,
• Homie Razavi,
• Geoffrey Dusheiko,
• C. Wendy Spearman,
• Saeed Hamid

Affiliations

Philippa C. Matthews

The Francis Crick Institute, 1 Midland Road, London, NW1 1AT, UK; Division of Infection and Immunity, University College London, Gower St, London WC1E 6BT, UK; Department of Infection, University College London Hospitals, 235 Euston Rd, London NW1 2BU, UK; Corresponding author. Address: The Francis Crick Institute, 1 Midland Road, London, NW1 1AT, UK.

Ponsiano Ocama

Department of Medicine, Makerere University College of Health Sciences, Kampala, Uganda

Su Wang

Cooperman Barnabas Medical Center, Florham Park, NJ, USA; Hepatitis B Foundation, Doylestown, PA, USA

Manal El-Sayed

Department of Paediatrics, Faculty of Medicine, Ain Shams University, Cairo, Egypt

Anna Turkova

Medical Research Council Clinical Trials Unit, University College London, 90 High Holborn London WC1V 6LJ, UK

Deborah Ford

Medical Research Council Clinical Trials Unit, University College London, 90 High Holborn London WC1V 6LJ, UK

Judith Torimiro

Chantal Biya International Reference Centre for Research on Prevention and Management of HIV/AIDS (CIRCB), Yaounde, Cameroon; Faculty of Medicine and Biomedical Sciences, University of Yaounde, Yaounde, Cameroon

Ana Cristina Garcia Ferreira

Ministry of Health, Health Surveillance Department, Department of Chronic Diseases and Sexually Transmitted Infections, SRTVN Quadra 701, Lote D, PO700 Building, CEP: 70719040, Brasília/DF, Brazil

Angélica Espinosa Miranda

Ministry of Health, Health Surveillance Department, Department of Chronic Diseases and Sexually Transmitted Infections, SRTVN Quadra 701, Lote D, PO700 Building, CEP: 70719040, Brasília/DF, Brazil

Fernando Pio De La Hoz Restrepo

Universidad Nacional de Colombia, Bogotá, Colombia

Emmanuel Seremba

Department of Medicine, Makerere University College of Health Sciences, Kampala, Uganda

Robinson Mbu

Faculty of Medicine and Biomedical Sciences, University of Yaounde, Yaounde, Cameroon

Calvin Q. Pan

Division of Gastroenterology and Hepatology, NYU Langone Health, NYU Grossman School of Medicine, NY, USA

Homie Razavi

Center for Disease Analysis Foundation, 1120 W South Boulder Rd Suite 102, Lafayette, CO 80026, USA

Geoffrey Dusheiko

Liver Unit, King’s College Hospital, Denmark Hill, London SE5 9RS, UK

C. Wendy Spearman

Division of Hepatology, Department of Medicine, Faculty of Health Sciences, University of Cape Town, South Africa

Saeed Hamid

Department of Medicine, Aga Khan University, Karachi, Pakistan